Read + Share
Amedeo Smart
Independent Medical Education
Koizumi S, Doi R, Aitake U, Lei X, et al. Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens. J Dermatol 2024;51:e203-e204.PMID: 38216840
Email
LinkedIn
Privacy Policy